Chemicals · Fiscal year end Dec 31

KOBAYASHI PHARMACEUTICAL CO.,LTD.

4967

小林製薬株式会社

FIGI BBG000BSYLZ34967.T4967 JPCorp. no. 4120001077402

Latest half-year results

First half · fiscal year to 2026-12 · filed 2026-08-07

For the first half of the fiscal year to 2026-12: Revenue ¥70.7 billion (+2.5% YoY), Ordinary income ¥3 billion (-58.5% YoY), Net income ¥1.1 billion (-64.1% YoY).

	This period	Year on year
Revenue	¥70.7bn	+2.5%
Ordinary profit	¥3.0bn	-58.5%
Net profit to owners	¥1.1bn	-64.1%

From the securities report on EDINET, which states no forecast. History via /v1/companies/4967/earnings-releases.

Financials

Japan GAAP · consolidated · fiscal year to 2025-12-31

Revenue: ¥165.7bn
Net income: ¥3.7bn
ROE: 1.7%
Equity ratio: 76.3%
Dividend / share: ¥104
Employees: 3,731

Revenue · ¥bn

Net income · ¥bn

Fiscal year	Revenue	Net income	Total assets	Net assets	ROE	EPS	Operating CF
2025-12-31	¥165.7bn	¥3.7bn	¥275.3bn	¥211.0bn	1.7%	¥49.19	¥25.6bn
2024-12-31	¥165.6bn	¥10.1bn	¥265.4bn	¥213.5bn	4.8%	¥135.42	¥11.2bn
2023-12-31	¥173.5bn	¥20.3bn	¥267.5bn	¥204.8bn	10.1%	¥268.16	¥18.4bn
2022-12-31	¥166.3bn	¥20.0bn	¥255.8bn	¥197.9bn	10.2%	¥259.63	¥31.9bn
2021-12-31	¥155.3bn	¥19.7bn	¥252.6bn	¥195.6bn	10.4%	¥252.36	¥22.4bn

Indicators

Computed by us from filings · fiscal year to 2025-12-31

Metric	Value	Percentile among listed companies
ROE, %	1.7	9.9
Ordinary margin	0.1025	69.1
Equity ratio, %	76.3	85
Revenue growth	0.0009	25.2
Net income growth	-0.6368	10.9
Operating cash flow / assets	0.0929	69

Policy-uncertainty measure1.17 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.

Regulation 2 Politics & geopolitics 3

Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change +1.04pt in 90 days; 1.5% held by other listed companies.

Results wording balance: +0.33. Proprietary text method; it describes the wording only and does not interpret context.

Via /v1/companies/4967/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them

Internal control, 2026-03-25: see filing 上記の評価の結果、当事業年度末日時点において、当社の財務報告に係る内部統制は有効であると判断した。 Filing

Segments, votes and tender offers

Stated in EDINET filings

Segments: Domestic Business, International Business, Other. /v1/companies/4967/segments

Latest voting result: 2026-03-27 · から第6号議案まで)〉第1号議案定款の一部変更の件 · passed. /v1/companies/4967/voting

Ownership changes

All companies →

2026-09-09

Purpose change+1.04pt

Oasis Management Company Ltd. changed its stated purpose for holding KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967): may_make_proposals, shareholder_value_engagement, undervaluation_thesis -> may_make_proposals, pure_investment, shareholder_value_engagement, undervaluation_thesis.

S100Z130Filer profile Original filing (PDF, Japanese)
2026-09-09

Increase+1.04pt

Oasis Management Company Ltd. raised holdings in KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967) to 14.41% from 13.37%.

S100Z130Filer profile Original filing (PDF, Japanese)
2026-05-13

Purpose change+0.31pt

Oasis Management Company Ltd. changed its stated purpose for holding KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967): may_make_proposals -> may_make_proposals, shareholder_value_engagement, undervaluation_thesis.

S100Y3KBFiler profile Original filing (PDF, Japanese)
2026-05-13

Increase+0.31pt

Oasis Management Company Ltd. raised holdings in KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967) to 13.37% from 13.06%.

S100Y3KBFiler profile Original filing (PDF, Japanese)
2025-12-26

Increase+2.96pt

Oasis Management Company Ltd. raised holdings in KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967) to 13.06% from 10.10%.

S100XCPNFiler profile Original filing (PDF, Japanese)
2024-12-25

Increase+2.56pt

Oasis Management Company Ltd. raised holdings in KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967) to 10.10% from 7.54%.

S100UZJCFiler profile Original filing (PDF, Japanese)
2024-12-25

Threshold

Holdings of Oasis Management Company Ltd. in KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967) moved above 10% (7.54% -> 10.10%).

S100UZJCFiler profile Original filing (PDF, Japanese)
2024-11-19

Increase+2.34pt

Oasis Management Company Ltd. raised holdings in KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967) to 7.54% from 5.20%.

S100USA9Filer profile Original filing (PDF, Japanese)
2024-10-23

Amendment0.00pt

Oasis Management Company Ltd. filed a correction to a 5% report on KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967).

S100UK9SFiler profile Original filing (PDF, Japanese)
2024-07-24

Stated it may make proposals

Oasis Management Company Ltd. states it may make proposals to the management of KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967) (first filing).

S100U3HMFiler profile Original filing (PDF, Japanese)

Trades by 5% holders

From the 60-day trade tables in 5% reports

Bought SoldHover a dot for the trade

Holder	Period	Net shares	Net % of shares	Avg. filed price	Range
Oasis Management Company Ltd.	2024-05-23 – 2026-09-02	+8,361,900	+10.69pt	¥5,518.46	¥5,252–5,983

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4967/trades.

5% filings

Large shareholding reports on 4967

Filed	Filer	Stake	Change	Stated purpose
2026-09-09	Oasis Management Company Ltd.	14.41%	+1.04pt	may make proposals pure investment shareholder value engagement undervaluation thesis
2026-05-13	Oasis Management Company Ltd.	13.37%	+0.31pt	may make proposals shareholder value engagement undervaluation thesis
2025-12-26	Oasis Management Company Ltd.	13.06%	+2.96pt	may make proposals
2024-12-25	Oasis Management Company Ltd.	10.10%	+2.56pt	may make proposals
2024-11-19	Oasis Management Company Ltd.	7.54%	+2.34pt	may make proposals
2024-10-23	Oasis Management Company Ltd.	5.20%	—	may make proposals
2024-07-24	Oasis Management Company Ltd.	5.20%	—	may make proposals
2022-11-08	Massachusetts Financial Services Company	4.39%	−1.23pt	pure investment
2022-08-19	Massachusetts Financial Services Company	5.62%	−1.28pt	pure investment
2022-04-06	Massachusetts Financial Services Company	6.90%	−1.03pt	pure investment

Cross-shareholdings

From the annual report's status of shareholdings

Listed strategic holdings: 54 issues
Book value: ¥11.2bn
Sold in the year: ¥1.5bn 5 issues
Bought in the year: ¥25m 12 issues
Mutual, both reports: 8
Held by listed cos.: 24

Holds	Book value	Shares vs. prior year	Mutual
MatsukiyoCocokara & Co 3088	¥3,446m	0.0%	both reports
㈱ＰＡＬＴＡＣ 8283	¥2,894m	0.0%	both reports
TOHO HOLDINGS CO.,LTD. 8129	¥870m	0.0%	both reports
Dai Nippon Printing Co.,Ltd. 7912	¥856m	0.0%	both reports
HAKUHODO DY HOLDINGS INCORPORATED 2433	¥698m	0.0%	both reports
㈱マンダム 4917	¥662m	-29.6%	no
SUNDRUG CO.,LTD. 9989	¥394m	+3.8%	no
OHKI HEALTHCARE HOLDINGS CO.,LTD. 3417	¥298m	+1.9%	both reports
ARATA CORPORATION 2733	¥281m	0.0%	both reports
PLANET,INC. 2391	¥223m	0.0%	no

Held by: HAKUHODO DY HOLDINGS INCORPORATED 2433, Dai Nippon Printing Co.,Ltd. 7912, MatsukiyoCocokara & Co 3088, 8283 8283, Inabata&Co.,Ltd. 8098, FUJI SEAL INTERNATIONAL,INC. 7864, OHKI HEALTHCARE HOLDINGS CO.,LTD. 3417, TOHO HOLDINGS CO.,LTD. 8129, SHIKOKU KASEI HOLDINGS CORPOLATION 4099, Rengo Co., Ltd. 3941, FUMAKILLALIMITED 4998, Toyo Seikan Group Holdings, Ltd. 5901 and 12 more

Purposes, all holdings and mutual flags via /v1/companies/4967/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2025-12-31

Shareholder	Shares	Ratio
individual holder	9,264,000	12.46%
(公財)小林財団	6,000,000	8.07%
日本マスタートラスト信託銀行㈱（信託口）	5,246,000	7.06%
オアシスジャパンストラテジックファンド	3,855,000	5.19%
individual holder	2,325,000	3.13%
individual holder	2,071,000	2.79%
オアシスジャパンストラテジックファンドＹ	2,039,000	2.74%
オアシスインベストメントⅡマスターファンド	1,946,000	2.62%
individual holder	1,863,000	2.51%
individual holder	1,700,000	2.29%

U.S. funds holding 4967

SEC Form N-PORT, reports to 2026-07-31

43 U.S. funds held 2,747,854 shares worth $95.7m.

Fund	Shares	Value	% of fund	As of
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS	731,801	$25.7m	0.004%	2026-07-31
VANGUARD DEVELOPED MARKETS INDEX FUND VANGUARD TAX-MANAGED FUNDS	498,704	$16.7m	0.005%	2026-06-30
iShares Core MSCI EAFE ETF iShares Trust	365,500	$12.8m	0.007%	2026-07-31
iShares MSCI EAFE Small-Cap ETF iShares Trust	182,100	$6.4m	0.048%	2026-07-31
Schwab International Equity ETF SCHWAB STRATEGIC TRUST	122,224	$4.5m	0.007%	2026-05-31

Up to 25 funds per stock via the API.

Get this as JSON

GET /v1/companies/4967
GET /v1/companies/4967/financials
GET /v1/companies/4967/details
GET /v1/companies/4967/segments
GET /v1/companies/4967/voting
GET /v1/companies/4967/tender-offers
GET /v1/companies/4967/indicators
GET /v1/companies/4967/earnings-releases
GET /v1/events?ticker=4967
GET /v1/companies/4967/trades         
GET /v1/companies/4967/cross-holdings 
GET /v1/companies/4967/brief

Plans from $9 a month · Documentation